Published • loading... • Updated
United Therapeutics (NASDAQ:UTHR) CEO Sells $5,212,555.00 in Stock
Summary by insidertrades.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
United Therapeutics (NASDAQ:UTHR) CEO Sells $5,212,555.00 in Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the business's stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $548.69, for a total transaction of $5,212,555.00. Following the transaction, the chief executive officer owned 40,513 shares of the company's stock, valued at approximately $22,229,077.97. This trade represents a 19.00% de…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
